| Name | Title | Contact Details |
|---|
WellAir provides an ecosystem for healthy indoor air by delivering innovative and powerful air disinfection technology and surface disinfection devices. Our best in class solutions are used worldwide in healthcare, education, commercial and industrial ...
Telesta Therapeutics is a biopharmaceutical company focused on the development, manufacturing and commercialization of transformative human therapeutics. Our main focus is on novel medicines that address major unmet medical needs, particularly in oncology. Our anchor product, MCNA, has completed a Phase III pivotal study in patients with non-muscle invasive bladder cancer that have failed the first line therapy, bacillus Calmette-Guérin (BCG). Telesta submitted a Biologics Licensing Application (BLA) for MCNA with the U.S. FDA on June 29, 2015 and is seeking, upon marketing approval in the U.S., to make MCNA available for patients and their physicians. Our ultimate goal is to transform the treatment landscape and prolong and improve the lives of those affected by bladder cancer, one of the most common types of cancers today.
Eagle Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing injectable products, primarily in the critical care and oncology areas, using the 505(b)(2) regulatory pathway.
Profil Institute for Clinical Research is a Chula Vista, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Metropolitan Omaha Medical Society is a Omaha, NE-based company in the Healthcare, Pharmaceuticals, and Biotech sector.